# Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

> clinical trial · VERIFIED · 2026-07-06

Status: NOT_YET_RECRUITING · Sponsor: Washington University School of Medicine · Condition: Mycosis Fungoides/Sezary Syndrome

- Company: Washington University School of Medicine
- Sector: Mycosis Fungoides/Sezary Syndrome
- Primary source: https://clinicaltrials.gov/study/NCT07682792

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.